Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07704047 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Clinical Study of FT1 in Patients With Short Bowel Syndrome

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The goal of this clinical trial is to learn if FT1 is safe and works to treat short bowel syndrome (SBS) in adults. It will also learn about the PK/PD profile of FT1. Researchers will compare FT1 to a placebo (a look-alike substance that contains no drug) to see if FT1 is safe and effective in patients with SBS. Participants will * Receive multiple injections of FT1 or placebo according to weight. * Visit the clinic for assessment.
Trial Details
NCT Number NCT07704047
Lead Sponsor Chongqing Peg-Bio Biopharm Co., Ltd.
Conditions
(from sponsor)		 Short Bowel Syndrome, SBS
Related terms Short Bowel Syndrome
Enrollment 8 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov